Literature DB >> 23171012

The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.

Meng-Sui Lee1, Ruey-Yi Lin, Yun-Ting Chang, Mei-Shu Lai.   

Abstract

BACKGROUND: Hospitalized psoriasis patients are known to have a higher risk of malignancy (e.g., nonmelanoma skin cancer [NMSC], lymphoma, and melanoma) than the general population; currently, it is unclear whether this risk is affected by psoriasis severity. The aim of this study was to compare the cancer risk of patients with mild and severe psoriasis and the general population.
METHODS: Data for this retrospective population-based cohort study were obtained from the Taiwan National Health Insurance Research Database. This study included 7061 patients with a first-time diagnosis of psoriasis. All study individuals were followed up until the end of 2007. The crude incidence density ratio and standardized incidence ratio (SIR) of NMSC, melanoma, and lymphoma were determined.
RESULTS: Among psoriasis patients, the most common cancer was NMSC (density ratio: 7.5); women were at a higher risk of NMSC than men (density ratios: 8.08 vs. 7.0). Psoriasis patients in the south geographic group or in the 50- to 59-year-old age group were most likely to develop NMSC. The NMSC SIR was higher among patients with severe psoriasis than among patients with mild psoriasis (SIR: 3.72 vs. 7.08). The lymphoma and melanoma SIR among patients with severe psoriasis was also high (lymphoma SIR: 4.85; melanoma: 11.01).
CONCLUSIONS: Psoriasis carries an elevated risk of NMSC and lymphoma. This effect is modified by the severity of psoriasis, age, gender, and geographic location.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2012        PMID: 23171012     DOI: 10.1111/j.1365-4632.2011.05310.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Personal history of psoriasis and risk of incident cancer among women: a population-based cohort study.

Authors:  W-Q Li; J Han; E Cho; S Wu; H Dai; M A Weinstock; A A Qureshi
Journal:  Br J Dermatol       Date:  2016-01-17       Impact factor: 9.302

2.  Use of nicorandil is Associated with Increased Risk for Gastrointestinal Ulceration and Perforation- A Nationally Representative Population-based study.

Authors:  Chien-Chang Lee; Shy-Shin Chang; Shih-Hao Lee; Yueh-Sheng Chen; Wan-Ting Hsu; Meng-Tse Gabriel Lee
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

3.  Psoriasis vulgaris and familial cancer risk- a population-based study.

Authors:  Romuald Maleszka; Katarzyna Paszkowska-Szczur; Ewa Soczawa; Magdalena Boer; Monika Różewicka-Czabańska; Joanna Wiśniewska; Aneta Mirecka; Lidia Krysztoforska; Zygmunt Adamski; Jan Lubinski; Tadeusz Dębniak
Journal:  Hered Cancer Clin Pract       Date:  2013-06-28       Impact factor: 2.857

Review 4.  Psoriasis and comorbidities: links and risks.

Authors:  Catherine Ni; Melvin W Chiu
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-04-17

5.  Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: an analysis of national representative claims database.

Authors:  Meng-Tse Gabriel Lee; Shih-Hao Lee; Shy-Shin Chang; Si-Huei Lee; Matthew Lee; Cheng-Chung Fang; Shyr-Chyr Chen; Chien-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study.

Authors:  Jiunn-Yih Wu; Meng-Tse Gabriel Lee; Si-Huei Lee; Shih-Hao Lee; Yi-Wen Tsai; Shou-Chien Hsu; Shy-Shin Chang; Chien-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Meng-Tse Gabriel Lee; Chih-Cheng Lai; I-Lin Wu; Yi-Wen Tsai; Shy-Shin Chang; Chien-Chang Lee
Journal:  BMC Pulm Med       Date:  2017-05-04       Impact factor: 3.317

Review 8.  Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.

Authors:  Akshitha Thatiparthi; Amylee Martin; Jeffrey Liu; Alexander Egeberg; Jashin J Wu
Journal:  Am J Clin Dermatol       Date:  2021-04-16       Impact factor: 7.403

9.  Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.

Authors:  Meng-Tse Gabriel Lee; Shih-Hao Lee; Shy-Shin Chang; Ya-Lan Chan; Laura Pang; Sue-Ming Hsu; Chien-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.

Authors:  Emmanouil Charakopoulos; Ioannis Spyrou; Nora-Athina Viniou; Nefeli Giannakopoulou; Sevastianos Hatzidavid; Panagiotis Theodorou Diamantopoulos
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.